Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
1 other identifier
observational
1,210
1 country
26
Brief Summary
The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2009
Shorter than P25 for all trials
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2008
CompletedFirst Posted
Study publicly available on registry
December 2, 2008
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedDecember 3, 2010
December 1, 2010
December 1, 2008
December 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Asthma control test
On the survey date
Secondary Outcomes (1)
Asthma control in mild, moderate and severe persistent asthma patients
On the survey date
Eligibility Criteria
Patient aged 12 years and older who established persistent asthma and currently treated with any inhaled corticosteroid for 3 months or longer.
You may qualify if:
- Established persistent asthma
- Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer
You may not qualify if:
- Currently participating or have participated in a study with an investigational compound within the last 30 days
- Current diagnosis of chronic obstructive pulmonary disease (COPD)
- Smoked more than 10 packs a year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (26)
Research Site
Amnat Charoen, Thailand
Research Site
Buriram, Thailand
Research Site
Chachoengsao, Thailand
Research Site
Chaiyaphum, Thailand
Research Site
Chanthaburi, Thailand
Research Site
Chiang Rai, Thailand
Research Site
Kalasin, Thailand
Research Site
Khon Kaen, Thailand
Research Site
Lopburi, Thailand
Research Site
Mae Hong Son, Thailand
Research Site
Mahasarakham, Thailand
Research Site
Nakhon Phanom, Thailand
Research Site
Nakhorn Ratchasima, Thailand
Research Site
Nan, Thailand
Research Site
Nong Khai, Thailand
Research Site
Samutsongkhram, Thailand
Research Site
Si Sa Ket, Thailand
Research Site
Sing Buri, Thailand
Research Site
Songkhla, Thailand
Research Site
Sukhothai Thani, Thailand
Research Site
Surat Thani, Thailand
Research Site
Trang, Thailand
Research Site
Trat, Thailand
Research Site
Ubon Ratchathani, Thailand
Research Site
Udon Thani, Thailand
Research Site
Yasothon, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bandit Thinkhamrop, PhD
Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University
- PRINCIPAL INVESTIGATOR
Watchara Boonsawat, MD. PhD
Department of Medicine, Faculty of Medicine, Khon Kaen University
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 1, 2008
First Posted
December 2, 2008
Study Start
May 1, 2009
Study Completion
November 1, 2009
Last Updated
December 3, 2010
Record last verified: 2010-12